BRIEF-GSK publishes long-term organ damage analysis for Benlysta By: Reuters: Company News March 03, 2016 at 10:46 AM EST * New long-term organ damage analysis published for GSK's Benlysta (belimumab) Read More >> Related Stocks: Gsk Plc ADR